Business UpdateJun 18, 2026, 03:35 PM
Cosmos Health's CosmoFarm Q2 Revenue Over $15M; Annualized Run-Rate $60M
AI Summary
CosmoFarm S.A., a wholly-owned subsidiary of Cosmos Health Inc., reported record revenue of over $15 million in the second quarter of 2026, achieving an annualized run-rate exceeding $60 million. The subsidiary significantly expanded its distribution network by adding over 80 new pharmacies. To sustain this accelerating growth, Cosmos Health is increasing capital expenditure at CosmoFarm, investing in new robotic automation and artificial intelligence systems, and expanding its facility size to enhance operational efficiency and accommodate higher volumes.
Key Highlights
- CosmoFarm S.A. achieved record revenue of over $15 million in Q2 2026.
- The subsidiary's annualized revenue run-rate now exceeds $60 million.
- CosmoFarm added over 80 new pharmacies to its distribution network.
- Cosmos Health is increasing capital expenditure at CosmoFarm.
- Investments include new robotic automation and artificial intelligence systems.
- The CosmoFarm facility is being expanded to accommodate higher volumes.
Price Impact
More from COSM